22 hours 58 minutes ago
It is the first gene therapy to be directly administered into the brain to treat aromatic L-amino acid decarboxylase (AADC) deficiency
23 hours 2 minutes ago
Positive opinion is based on data from clinical trials which showed improvement in lung function
3 days 23 hours ago
Thousands usually prescribed sleeping pills could be offered app-based treatment
3 days 23 hours ago
Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury
4 days 21 hours ago
Comparisons with other tests available have shown that blood test has greater sensitivity for the detection of bowel cancer
4 days 21 hours ago
Gifford is supporting the launch with a philanthropic donation of £14.7m
5 days 21 hours ago
Device delivers currents to the brain to restore activity usually lowered in depression patients
5 days 21 hours ago
Orally available EP395 has met all endpoints in safety and is now undergoing phase 2 planning
6 days 22 hours ago
Authorisation of the treatment is based on results from the phase 3 trial
6 days 22 hours ago
Team at Imperial College London will expand MELODY study to include immunosuppressed young people
1 week ago
Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells
1 week ago
PT027 is being developed through a partnership involving AstraZeneca and Avillion
1 week 3 days ago
Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out
1 week 3 days ago
The therapy offers patients a convenient alternative to surgery or injections and can be administered at home
1 week 4 days ago
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
1 week 4 days ago
The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens
1 week 5 days ago
The project will analyse risks from Sano Genetics’ data from 3,000 UK adults suffering from long COVID
1 week 5 days ago
Nirsevimab is the first investigational immunisation designed to protect all infants across the RSV season with a single dose
1 week 6 days ago
NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy
1 week 6 days ago
Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes
Checked
54 minutes 25 seconds ago
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Subscribe to Pharma times RSS Feed feed